ENTRY       D11244                      Drug
NAME        Vanucizumab (USAN/INN)
FORMULA     C6529H10033N1733O2038S46
EXACT_MASS  146795.1871
MOL_WEIGHT  146885.9006
SEQUENCE    (Heavy chain)
            QVQLVQSGAE VKKPGASVKV SCKASGYTFT GYYMHWVRQA PGQGLEWMGW INPNSGGTNY
            AQKFQGRVTM TRDTSISTAY MELSRLRSDD TAVYYCARSP NPYYYDSSGY YYPGAFDIWG
            QGTMVTVSSA SVAAPSVFIF PPSDEQLKSG TASVVCLLNN FYPREAKVQW KVDNALQSGN
            SQESVTEQDS KDSTYSLSST LTLSKADYEK HKVYACEVTH QGLSSPVTKS FNRGECDKTH
            TCPPCPAPEL LGGPSVFLFP PKPKDTLMIS RTPEVTCVVV DVSHEDPEVK FNWYVDGVEV
            HNAKTKPREE QYNSTYRVVS VLTVLHQDWL NGKEYKCKVS NKALPAPIEK TISKAKGQPR
            EPQVCTLPPS RDELTKNQVS LSCAVKGFYP SDIAVEWESN GQPENNYKTT PPVLDSDGSF
            FLVSKLTVDK SRWQQGNVFS CSVMHEALHN HYTQKSLSLS PGK
            (heavy chain)
            EVQLVESGGG LVQPGGSLRL SCAASGYTFT NYGMNWVRQA PGKGLEWVGW INTYTGEPTY
            AADFKRRFTF SLDTSKSTAY LQMNSLRAED TAVYYCAKYP HYYGSSHWYF DVWGQGTLVT
            VSSASTKGPS VFPLAPSSKS TSGGTAALGC LVKDYFPEPV TVSWNSGALT SGVHTFPAVL
            QSSGLYSLSS VVTVPSSSLG TQTYICNVNH KPSNTKVDKK VEPKSCDKTH TCPPCPAPEL
            LGGPSVFLFP PKPKDTLMIS RTPEVTCVVV DVSHEDPEVK FNWYVDGVEV HNAKTKPREE
            QYNSTYRVVS VLTVLHQDWL NGKEYKCKVS NKALPAPIEK TISKAKGQPR EPQVYTLPPC
            RDELTKNQVS LWCLVKGFYP SDIAVEWESN GQPENNYKTT PPVLDSDGSF FLYSKLTVDK
            SRWQQGNVFS CSVMHEALHN HYTQKSLSLS PGK
            (Light chain)
            DIQMTQSPSS LSASVGDRVT ITCSASQDIS NYLNWYQQKP GKAPKVLIYF TSSLHSGVPS
            RFSGSGSGTD FTLTISSLQP EDFATYYCQQ YSTVPWTFGQ GTKVEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (light chain)
            QPGLTQPPSV SVAPGQTARI TCGGNNIGSK SVHWYQQKPG QAPVLVVYDD SDRPSGIPER
            FSGSNSGNTA TLTISRVEAG DEADYYCQVW DSSSDHYVFG TGTKVTVLSS ASTKGPSVFP
            LAPSSKSTSG GTAALGCLVK DYFPEPVTVS WNSGALTSGV HTFPAVLQSS GLYSLSSVVT
            VPSSSLGTQT YICNVNHKPS NTKVDKKVEP KSC
            (multichain; H22-H96, H156-H216, H236-l213, H242-h232, H245-h235, H277-H337, H383-H441, h22-h96, h150-h206, h226-L214, h267-h327, h373-h431, L23-L88, L134-L194, l22-l87, l137-l193)
  TYPE      Peptide
EFFICACY    Antineoplastic
  TYPE      Monoclonal antibody, bispecific antibody
TARGET      ANGPT2 [HSA:285] [KO:K05466]
            VEGFA [HSA:7422] [KO:K05448]
  PATHWAY   hsa01521(7422)  EGFR tyrosine kinase inhibitor resistance
            hsa04010(285+7422)  MAPK signaling pathway
            hsa04370(7422)  VEGF signaling pathway
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Growth factors (RTK-binding)
                VEGFA
                 D11244  Vanucizumab (USAN/INN)
                ANGPT2
                 D11244  Vanucizumab (USAN/INN)
DBLINKS     CAS: 1448221-05-3
            PubChem: 384585222
///
